effectiveness of local Tranexamic Acid on Epistaxis Control in patients with antiplateletes therapy(ASA, plavix)
Not Applicable
- Conditions
- Epistaxis.??????? ?? ????
- Registration Number
- IRCT201509088872N9
- Lead Sponsor
- Tehran University of Medical Sciences -Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Inclusion Criteria: All patients with epistaxis and history of consumption of ASA and Plavix whom referring to the emergency department.
Exclusion Criteria
Trauma patients; history of anticoagulants drug consumption; Inherited bleeding disorders; Hemophiliacs; Inherited platelet disorders; Shock; Lack of consent; patients with visible bleeding vessel; history of renal disease; INR> 1.5
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bleeding control time. Timepoint: every 5 minutes from the start point until the bleeding stops. Method of measurement: measured by stopwatch, per minute.
- Secondary Outcome Measures
Name Time Method Bleeding recurrence. Timepoint: first 24 hours and the first week. Method of measurement: measured by watch.;Patient's satisfaction. Timepoint: within discharge. Method of measurement: by VAS measurment system (10 points mark).